Phathom Pharmaceuticals
PHAT
PHAT
61 hedge funds and large institutions have $719M invested in Phathom Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+14
Holders Change %
+29.79%
% of All Funds
1.25%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.1%
New
20
Increased
21
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$23M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
$28M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$5.84M |
| 4 |
JPMorgan Chase & Co
New York
|
$5.27M |
| 5 |
BlackRock
New York
|
$23.9M |
